|
1
|
Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang
SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, et al: Pancreatic
neuroendocrine tumors: A review of serum biomarkers, staging and
management. World J Gastroenterol. 26:2305–2322. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Sun J, Song Y, Gao P, Wang X,
Chen M, Li Y and Wu Z: Roles of fusion genes in digestive system
cancers: Dawn for cancer precision therapy. Crit Rev Oncol Hematol.
171:1036222022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xia C, Dong X, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China
and United States, 2022: Profiles, trends, and determinants. Chin
Med J (Engl). 135:584–590. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: good or bad news from the 2018
global cancer statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, An J, He S, Liao C, Wang J and Tuo
B: Chloride intracellular channels as novel biomarkers for
digestive system tumors (review). Mol Med Rep. 24:6302021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li HS, He T and Yang LL: Adenosquamous
carcinoma of the digestive system: A literature review. Scand J
Gastroenterol. 55:1268–1276. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Xia D, Wang RX, Zhang YT, Zhang
SY, Yang C, Pan XR and Tong JH: Identification of potential
biomarkers for digestive system cancers from serum-derived
extracellular vesicle RNA. Clin Chim Acta. 531:36–47. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wen R, Lin P, Wu Y, Yin H, Huang W, Guo D,
Peng Y, Liu D, He Y and Yang H: Diagnostic value of CEUS LI-RADS
and serum tumor markers for combined
hepatocellular-cholangiocarcinoma. Eur J Radiol. 154:1104152022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Z, Miao L, Wang S, Zhao Y, Xie Y,
Yun H, Ren Z, Wang G, Teng M and Li Y: Study on the expression of
c-Met in gastric cancer and its correlation with preoperative serum
tumor markers and prognosis. World J Surg Oncol. 20:1–204.
2022.
|
|
10
|
Wu G, Li X, Seo H, Mclendon BA, Kramer AC,
Bazer FW and Johnson GA: Osteopontin (OPN)/secreted phosphoprotein
1 (SPP1) binds integrins to activate transport of ions across the
porcine placenta. Front Biosci (Landmark Ed). 27:1172022.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Yang R, Sun X, Miao S, Lu T, Wang Y,
Wo Y and Jiao W: Identification of SPP1 as a promising biomarker to
predict clinical outcome of lung adenocarcinoma individuals. Gene.
679:398–404. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Du W, Chen Z and Xiang C:
Upregulation of PD-L1 by SPP1 mediates macrophage polarization and
facilitates immune escape in lung adenocarcinoma. Exp Cell Res.
359:449–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei R, Wong J, Lyu P, Xi X, Tong O, Zhang
SD, Yuen HF, Shirasawa S and Kwok HF: In vitro and clinical data
analysis of Osteopontin as a prognostic indicator in colorectal
cancer. J Cell Mol Med. 22:4097–4105. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Changchien CY, Chang HH, Dai MS, Tsai WC,
Tsai HC, Wang CY, Shen MS, Cheng LT, Lee HS, Chen Y, et al:
Distinct JNK/VEGFR signaling on angiogenesis of breast
cancer-associated pleural fluid based on hormone receptor status.
Cancer Sci. 112:781–791. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pang X, Xie R, Zhang Z, Liu Q, Wu S and
Cui Y: Identification of SPP1 as an extracellular matrix signature
for metastatic castration-resistant prostate cancer. Front Oncol.
9:9242019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang L, Holtzinger A, Jagan I, Begora M,
Lohse I, Ngai N, Nostro C, Wang R, Muthuswamy LB, Crawford HC, et
al: Ductal pancreatic cancer modeling and drug screening using
human pluripotent stem cell- and patient-derived tumor organoids.
Nat Med. 21:1364–1371. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lao L, Shen J, Tian H, Zhong G, Murray SS
and Wang JC: Secreted phosphoprotein 24kD (Spp24) inhibits growth
of hepatocellular carcinoma in vivo. Environ Toxicol Pharmacol.
51:51–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Leng X, Yang J, Liu T, Zhao C, Cao Z, Li
C, Sun J and Zheng S: A bioinformatics framework to identify the
biomarkers and potential drugs for the treatment of colorectal
cancer. Front Genet. 13:10175392022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ren L, Fang X, Shrestha SM, Ji Q, Ye H,
Liang Y, Liu Y, Feng Y, Dong J and Shi R: LncRNA SNHG16 promotes
development of oesophageal squamous cell carcinoma by interacting
with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett.
27:892022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang C and Gong A: Integrated
bioinformatics analysis for differentially expressed genes and
signaling pathways identification in gastric cancer. Int J Med Sci.
18:792–800. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Li H, Zhou L, Yu L, Che F and
Heng X: Modified nodal stage of esophageal cancer based on the
evaluation of the hazard rate of the negative and positive lymph
node. BMC Cancer. 20:12002020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsuda T, Ohashi M, Tsujiura M, Ida S,
Kumagai K, Nunobe S, Sano T and Hiki N: Shorter survival of
patients with upper-third gastric cancer preoperatively diagnosed
as stage IA compared with those with middle to lower lesions. Ann
Surg Oncol. 27:276–283. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y and Liu Z: Oncolytic virotherapy
for malignant tumor: Current clinical status. Curr Pharm Des.
25:4251–4263. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong O, Jung MR, Kang JH and Ryu SY:
Prognostic performance of preoperative staging: Assessed by using
multidetector computed tomography-between the new clinical
classification and the pathological classification in the eighth
American joint committee on cancer classification for gastric
carcinoma. Ann Surg Oncol. 27:545–551. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pobłocki J, Jasińska A, Syrenicz A,
Andrysiak-Mamos E and Szczuko M: The neuroendocrine neoplasms of
the digestive tract: Diagnosis, treatment and nutrition. Nutrients.
12:14372020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gothlin EA, Lagergren K, Othman L,
Montgomery S, Andersson G and Tina E: Evaluation of
SPP1/osteopontin expression as predictor of recurrence in tamoxifen
treated breast cancer. Sci Rep. 10:14512020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bie T and Zhang X: Higher expression of
SPP1 predicts poorer survival outcomes in head and neck cancer. J
Immunol Res. 2021:85695752021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang M, Sun X, Xin H, Wen Z and Cheng Y:
SPP1 promotes radiation resistance through JAK2/STAT3 pathway in
esophageal carcinoma. Cancer Med. 11:4526–4543. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang H, Chen J, Han X, Feng Y and Wang F:
Upregulation of SPP1 is a marker for poor lung cancer prognosis and
contributes to cancer progression and cisplatin resistance. Front
Cell Dev Biol. 9:6463902021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z,
Ding X, Bao R, Hong L, Jia W, et al: Single-cell and spatial
analysis reveal interaction of FAP+ fibroblasts and
SPP1+ macrophages in colorectal cancer. Nat Commun.
13:17422022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu C, Sun L, Jiang C, Zhou H, Gu L, Liu Y
and Xu Q: SPP1, analyzed by bioinformatics methods, promotes the
metastasis in colorectal cancer by activating EMT pathway. Biomed
Pharmacother. 91:1167–1177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pang X, Zhang J, He X, Gu Y, Qian BZ, Xie
R, Yu W, Zhang X, Li T, Shi X, et al: SPP1 promotes enzalutamide
resistance and epithelial-mesenchymal-transition activation in
castration-resistant prostate cancer via PI3K/AKT and ERK1/2
pathways. Oxid Med Cell Longev. 2021:58066022021. View Article : Google Scholar : PubMed/NCBI
|
